Nature Genetics
18, 378 - 381 (1998)
doi:10.1038/ng0498-378
Ribozyme-mediated trans-splicing of a trinucleotide repeatLeonidas A. Phylactou1, 2, Charlotte Darrah1
& Matthew J.A. Wood1
1Department of Human Anatomy, Oxford University, South Parks Road, Oxford OX1 3QX, United Kingdom.
2e-mail: leonidas.phylactou@anat.ox.ac.uk Trinucleotide repeat expansions (TREs) are a recently described class of mutations characterized by a change in the size of the genomic fragment due to amplification of the repeated unit. A number of diseases have been attributed to TRE, including Huntington disease and myotonic dystrophy (DM; refs 1−3), but attempts at genetic therapy have yet to prove successful. A potential therapeutic approach would be to repair the expanded repeat using the trans-splicing ability of group I intron ribozymes4. We have used DM as a model to test this hypothesis. A group I intron ribozyme (DMPK-RZ1) was designed to modify the TRE at the 3' end of the human myotonic dystrophy protein kinase (DMPK) transcript5−8. DMPK-RZ1 was shown to ligate a small DMPK mRNA fragment, contained within the ribozyme, to a simple DMPK-target RNA in vitro. It also modified a larger target transcript, leading to replacement of twelve repeats with five repeats, both in vitro and in mammalian cells. Finally, this ribozyme successfully replaced the 3' end of endogenous DMPK mRNA in fibroblasts with a different 3' region. Ribozyme-mediated RNA repair may thus form a novel therapeutic strategy for diseases associated with repeat expansions.
REFERENCES
- Ashley, C.T., Jr. & Warren, S.T. Trinucleotide repeat expansion and human disease. Annu. Rev. Genet. 29, 703−728 (1995). | Article | PubMed | ISI | ChemPort |
- Bates, G. & Lehrach, H. Trinucleotide repeat expansions and human genetic disease. Bioessays 16, 277−284 (1994). | PubMed | ISI | ChemPort |
- Timchenko, L.T. & Caskey, C.T. Trinucleotide repeat disorders in humans: discussions of mechanisms and medical issues. FASEB J. 10, 1589−1597 (1996). | PubMed | ISI | ChemPort |
- Sullenger, B.A. & Cech, T.R. Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 371, 619−622 (1994). | Article | PubMed | ISI | ChemPort |
- Davies, K.E. et al. Linkage analysis of myotonic dystrophy and sequences on chromosome 19 using a cloned complement 3 gene probe. J. Med. Genet. 20, 259−263 (1983). | PubMed | ISI | ChemPort |
- Buxton, J. et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355, 547−548 (1992). | Article | PubMed | ISI | ChemPort |
- Brook, J.D. et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68, 799−808 (1992). | Article | PubMed | ISI | ChemPort |
- Mahadevan, M. et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255, 1253−1255 (1992). | PubMed | ISI | ChemPort |
- Harper, P.S. Myotonic Dystrophy. (WB Saunders, Phildelphia, 1989).
- Shelbourne, P. & Johnson, K. Myotonic dystrophy: another case of too many repeats? Hum. Mutat. 1.183−189 (1992). | PubMed | ChemPort |
- Tsilfidis, C., MacKenzie, A.E., Mettler, G., Barcelo, J. & Korneluk, R.G. Correlation between CTG trinucleotide repeat length and frequency of severecongenital myotonic dystrophy. Nature Genet. 1, 192−195 (1992). | PubMed | ISI | ChemPort |
- Cech, T.R., Zaug, A.J. & Grabowski, P.J. In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487−496 (1981). | Article | PubMed | ISI | ChemPort |
- Guerrier-Takada, C. & Altman, S. Catalytic activity of an RNA molecule prepared by transcription in vitro. Science 223, 285−286 (1984). | PubMed | ChemPort |
- Rossi, J.J., Controlled, targeted, intracellular expression of ribozymes: progress and problems. Trends Biotech. 13, 301−306 (1995). | Article | ISI | ChemPort |
- Birikh, K.R., Heaton, P.A. & Eckstein, F. The structure, function and application of the hammerhead ribozyme. Eur. J. Biochem. 245, 1−16 (1997). | PubMed | ISI | ChemPort |
- Kiehntopf, M., Esquivel, E.L., Brach, M.A. & Herrmann, F. Clinical applications of ribozymes. Lancet 345, 1027−1031 (1995). | Article | PubMed | ISI | ChemPort |
- Kilpatrick, M.W. et al. Delivery of a hammerhead ribozyme specifically down-regulates the production of fibrillin-1 by cultured dermal fibroblasts. Hum. Mol. Genet. 5, 1939−1944 (1996). | Article | PubMed | ISI | ChemPort |
- Ohta, Y., Kijima, H., Ohkawa, T., Kashani-Sabet, M. & Scanlon, K.J. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res. 24, 938−942 (1996). | Article | PubMed | ISI | ChemPort |
- Sarver, N. et al. Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222−1225 (1990). | PubMed | ISI | ChemPort |
- Cech, T.R. Self-splicing of group I introns. Annu. Rev. Biochem. 59, 543−568 (1990). | Article | PubMed | ISI | ChemPort |
- Jones, J.T., Lee, S.W. & Sullenger, B.A. Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Med. 2, 643−648 (1996). | PubMed | ISI | ChemPort |
- Carango, P., Noble, J.E., Marks, H.G. & Funanage, V.L. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy. Genomics 18, 340−348 (1993). | Article | PubMed | ISI | ChemPort |
- Young, B., Herschlag, D. & Cech, T.R. Mutations in a nonconserved sequence of the Tetrahymena ribozyme increase activity and specificity. Cell 67, 1007−1019 (1991). | Article | PubMed | ISI | ChemPort |
- Johnson, K.J. et al. Is myotonic dystrophy a single-gene disorder? Biochem. Soc. Trans. 24, 510−513 (1996). | PubMed | ISI | ChemPort |
- Hamshere, M.G. & Brook, J.D. Myotonic dystrophy, knockouts, warts and all. Trends Genet. 12, 332−334 (1996). | Article | PubMed | ISI | ChemPort |
- Jansen, G. et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nature Genet. 13, 316−324 (1996). | PubMed | ISI | ChemPort |
- Reddy, S. et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nature Genet. 13, 325−334 (1996). | PubMed | ISI | ChemPort |
- Klesert, T.R., Otten, A.D., Bird, T.D. & Tapscott, S.J. Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of DMAHP. Nature Genet. 16, 402−106 (1997). | PubMed | ISI | ChemPort |
- Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. & Housman, D.E. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA 94, 7388−7393 (1997). | Article | PubMed | ChemPort |
- Shaw, D.J. et al. Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 18, 673−679 (1993). | PubMed | ISI | ChemPort |
|
